Block Copolymer Micelle for Nucleic Acid Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleic acid delivery systems face challenges with cytotoxicity and inefficiency in delivering nucleic acids to target cells, particularly with cationic polymers and lipids, which have limitations in nucleic acid introduction and gene expression efficiency.
Innovation Solution
A block copolymer composition with a polyalkylene glycol segment and a cationic polymer segment, specifically a poly(amino acid) derivative, is used, where the mol percentage of cationic groups is between 25% and 90%, forming a polymeric micelle that reduces cytotoxicity and enhances nucleic acid introduction and gene expression efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cationic polymers are used as nucleic acid carriers, then nucleic acid complexation is achieved, but cytotoxicity increases and nucleic acid introduction efficiency remains insufficient
Solution Approach 1:
The invention divides the carrier system into two distinct components: a block copolymer (comprising hydrophilic and cationic segments) and a separate cationic polymer. This segmentation allows each component to perform its specialized function - the block copolymer provides biocompatibility and structural framework while the cationic polymer provides nucleic acid binding - thereby achieving efficient nucleic acid delivery with reduced cytotoxicity
Solution Approach 2:
The invention creates a composite carrier system combining a block copolymer (with hydrophilic polyethylene glycol segments and cationic polyamino acid segments) and a cationic polymer. This composite structure leverages the advantages of both materials: the hydrophilic blocks provide steric stability and reduced immunogenicity, while the cationic components enable nucleic acid complexation and cellular uptake, achieving synergistic effects that resolve the contradiction between efficiency and toxicity
2Reliability
If cationic lipids are used for nucleic acid delivery, then certain positive results are achieved in vitro, but desired results are not achieved in vivo
Solution Approach 1:
The invention modifies the physical and chemical parameters of the carrier system by using a block copolymer with specific architectural features (amphiphilic structure with hydrophilic polyethylene glycol blocks and cationic polyamino acid blocks) combined with cationic polymers. This parameter optimization enables the formation of stable polymeric micelles with controlled size, charge, and nucleic acid binding capacity, which maintain effectiveness from in vitro to in vivo applications
3Reliability
If homopolymer with amine groups is used, then nucleic acid introduction efficiency improves, but cytotoxicity reduction is insufficient
Solution Approach 1:
The invention segments the polymer structure into distinct functional blocks: hydrophilic polyethylene glycol blocks that provide biocompatibility and steric protection, and cationic polyamino acid blocks that provide nucleic acid binding. This segmentation allows the carrier to achieve high nucleic acid introduction efficiency through the cationic blocks while the hydrophilic blocks simultaneously reduce cytotoxicity by providing steric stabilization and reducing non-specific interactions with cells
Solution Approach 2:
The block copolymer structure exhibits local quality differentiation where different segments perform different functions: the hydrophilic polyethylene glycol segments provide steric protection and reduce immunogenicity at the carrier surface, while the cationic polyamino acid segments localized within the structure provide strong nucleic acid binding. This spatial differentiation of functional properties enables simultaneous optimization of efficiency and biocompatibility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves superior nucleic acid introduction efficiency with reduced cytotoxicity, making it suitable for pharmaceutical applications in nucleic acid therapy, as demonstrated by improved transfection efficiency and low cytotoxicity in both in vitro and in vivo studies.
Implementation Method 1
The present inventors have reported that self-assembly of a block copolymer which has a cationic polymer segment containing amine groups on its side chains and an uncharged hydrophilic polymer segment such as polyethylene glycol (PEG) a polyion complex (PIC) yields a polymeric micelle encapsulating a nucleic acid
Implementation Method 2
Typical synthetic carriers include cationic lipids and cationic polymers, which can form an ion complex with DNA, which is negatively charged
Data Source
Figure 1(a)~1(b)
Figure 2
Figure 3~4
AI summary
An excellent nucleic acid delivery composition is provided which has reduced cytotoxicity and improved nucleic acid introduction efficiency and gene expression efficiency. The composition comprises: a block copolymer having an uncharged hydrophilic polymer segment and a cationic polymer segment; a cationic polymer; and a nucleic acid, wherein the mol percentage (B/H ratio) of the cationic groups of the block copolymer to the total cationic groups of the block copolymer and the cationic polymer is between 25% and 90%.